FDA Inspection
AndersonBrecon Inc.AndersonBrecon Inc. – FDA Inspection, Jan 10, 2019
Record Details
This FDA Inspection record concerns AndersonBrecon Inc., with an inspection on January 10, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 547fb415-fdae-4a35-9142-319885539957
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1077016
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of AndersonBrecon Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 8, 2025 | Not classified | Chicago District Office | |
| February 25, 2022 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| July 19, 2016 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| September 20, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 7, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AndersonBrecon Inc.
- FDA Inspection 1271016 - 2025-05-08
- FDA Inspection 1163069 - 2022-02-25
- FDA Inspection 983024 - 2016-07-19
- FDA Inspection 849321 - 2013-09-20
- FDA Inspection 748939 - 2011-10-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.